SCHEMBL8148384

SCHEMBL8148384

CCc1nc(-c2ccc(Cl)cc2Cl)cn1C(CC)C1CC1

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7133264 0.87 CRHR1 (0.41) CRHR1
SCHEMBL8146323 0.86 CRHR1 (0.38) CRHR1
SCHEMBL8140649 0.79
SCHEMBL7133605 0.78 CRHR1 (0.40) CRHR1
SCHEMBL8152498 0.77
SCHEMBL8128572 0.75 HSP90AA1 (0.42) CRHR1
SCHEMBL8128658 0.75 CRHR1 (0.41) CRHR1
SCHEMBL8146663 0.74 HSP90AA1 (0.41) CRHR1
SCHEMBL8151084 0.74 CRHR1 (0.37) CRHR1
SCHEMBL7036316 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994877-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Du Pont Pharmaceuticals Company (US) 2000-04-26 EP disclosed
WO-1999001454-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS DU PONT PHARMACEUTICALS COMPANY (US) 1999-01-14 WO disclosed